Scott Kellen
Vermögen: 399 054 $ am 31.05.2026
Vermögen: 399 054 $ am 31.05.2026
Scott Kellen currently works at DiaMedica Therapeutics, Inc., as Chief Financial Officer & Secretary from 2018.
Mr. Kellen also formerly worked at Transoma Medical, Inc., as Finance Director from 2007 to 2009, ev3, Inc., as Controller from 2005 to 2007, Kips Bay Medical, Inc., as COO, CFO, Secretary, VP & Head-Investor Relations from 2012 to 2015, Sun Biopharma, Inc., as Chief Financial Officer & Vice President, Deloitte & Touche LLP, as Senior Audit Manager from 2003 to 2005, and Panbela Therapeutics, Inc., as Chief Financial Officer, Secretary, CAO & VP from 2015 to 2018.
Mr. Kellen received his undergraduate degree from the University of South Dakota.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 34’330 ( 0.06% ) | 205 637 $ | 31.05.2026 | |
| 01.06.2026 | 32’290 ( -.--% ) | 193 417 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Finanzdirektor/CFO | 01.04.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
| SUN BIOPHARMA INC | Finanzdirektor/CFO | 01.04.2018 |
Transoma Medical, Inc.
Transoma Medical, Inc. Medical/Nursing ServicesHealth Services Manufactures and distributes implantable, wireless diagnostic and monitoring systems | Finanzdirektor/CFO | 01.05.2009 |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and distributes medical devices | Comptroller/Controller/Auditor | 01.10.2007 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Comptroller/Controller/Auditor | 01.04.2005 |
Sun Biopharma, Inc. /Old/
Sun Biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and distributes medical devices | Health Technology |
DiaMedica Therapeutics, Inc.
DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Kips Bay Medical, Inc.
Kips Bay Medical, Inc. Medical SpecialtiesHealth Technology Engages in the development, manufacturing and commercialization of proprietary external saphenous vein support technology | Health Technology |
Sun Biopharma, Inc. /Old/
Sun Biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
University of South Dakota
University of South Dakota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transoma Medical, Inc.
Transoma Medical, Inc. Medical/Nursing ServicesHealth Services Manufactures and distributes implantable, wireless diagnostic and monitoring systems | Health Services |
Panbela Therapeutics, Inc.
Panbela Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen